USE OF MANNOSYLATED LIPOSOMES FOR INVIVO TARGETING OF A MACROPHAGE ACTIVATOR AND CONTROL OF ARTIFICIAL PULMONARY METASTASES

被引:32
作者
BARRATT, GM [1 ]
NOLIBE, D [1 ]
YAPO, A [1 ]
PETIT, JF [1 ]
TENU, JP [1 ]
机构
[1] CEA,INST PROTECT & SURETE NUCL,DEPT PROTECT SANIT,SPEGTCE,TOXICOL TRANSURANIENS LAB,F-91680 BRUYERES CHATEL,FRANCE
来源
ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY | 1987年 / 138卷 / 03期
关键词
Liposome; Mannose; Macrophage; MDP; Tumeur; Ciblage thérapeutique; Immunomodulation; Endotoxine; MTP-CHOL; Metastases; Rat; Métastases; Tumour; Drug delivery; Endotoxin;
D O I
10.1016/S0769-2625(87)80054-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
From a mannosylated mycobacterial phospholipid, we prepared an original type of liposome which was taken up by macrophages by means of the mannose/fucose receptor. When a lipophilic immunomodulator, MDP-L-alanylcholesterol (MTP-CHOL) was included in such liposomes, they were able to activate WAG rat alveolar macrophages for cytotoxicity against syngeneic tumour cells in vitro. The presence of suboptimal levels of endotoxin was essential for this activation. Cytotoxic macrophages could also be induced in vivo by injecting immunomodulator-loaded liposomes intravenously 24 h before harvesting macrophages. A decrease in experimental pulmonary colonies arising from i.v. injected tumour cells was observed following repeated administration of such liposomes. © 1987, Elsevier. All rights reserved.
引用
收藏
页码:437 / 450
页数:14
相关论文
共 38 条
[1]   MURAMYL PEPTIDES - IMMUNOMODULATORS, SLEEP FACTORS, AND VITAMINS [J].
ADAM, A ;
LEDERER, E .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (02) :111-152
[2]   PHOSPHOLIPID VESICLE TARGETING USING SYNTHETIC GLYCOLIPID AND OTHER DETERMINANTS [J].
BALDESCHWIELER, JD .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 446 :349-367
[3]  
BALLOU CE, 1963, J BIOL CHEM, V238, P69
[4]   PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING MANNOSYLATED PHOSPHOLIPIDS CAPABLE OF TARGETING DRUGS TO MACROPHAGES [J].
BARRATT, G ;
TENU, JP ;
YAPO, A ;
PETIT, JF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 862 (01) :153-164
[5]  
BARRATT G, 1986, BIOL PROPERTIES PEPT, P249
[6]  
BLOKSMA N, 1985, CANCER IMMUNOL IMMUN, V19, P205
[7]  
BROWNBILL AF, 1985, CANCER IMMUNOL IMMUN, V20, P11
[8]  
DAEMEN T, 1986, CANCER RES, V46, P4330
[9]   MINIMAL STRUCTURAL REQUIREMENTS FOR ADJUVANT ACTIVITY OF BACTERIAL PEPTIDOGLYCAN DERIVATIVES [J].
ELLOUZ, F ;
ADAM, A ;
CIORBARU, R ;
LEDERER, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 59 (04) :1317-1325
[10]  
FIDLER IJ, 1985, CANCER RES, V45, P4714